Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients".
Picchio
Gastón
G
De Meyer
Sandra
S
de Béthune
Marie-Pierre
MP
D002219:Carbamates / Q000494:pharmacology*; D000069454:Darunavir; D024882:Drug Resistance, Viral / Q000235:genetics; D005663:Furans; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D013449:Sulfonamides / Q000494:pharmacology* / Q000627:therapeutic use*; D016896:Treatment Outcome
D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D013449:Sulfonamides; C095108:amprenavir; D000069454:Darunavir